Stockholm Life Tech
Making research and innovation infrastructures available
Stockholm Life Tech is a three-year project that started in 2020 with funding from the European Regional Development Fund. Project owner is Region Stockholm, and the project parties are Akademiska Hus, Flemingsberg Science, Karolinska Institutet, Karolinska Institutet Science Park, Karolinska University Hospital, and Stockholm Science City. The purpose of the project is to further develop research and innovation infrastructures as well as making them more available for companies.
This includes opening up the advanced development and production environments in Flemingsberg and Hagastaden for small and medium-sized companies.
Goals of the project:
- To increase growth in small and medium-sized life science companies in the two strong life science environments Flemingsberg and Hagastaden
- Making laboratories and research and innovation infrastructures available to companies in and around the two strong life science environments
- To increase the Stockholm region’s attractiveness with a special focus on life science
The goal is to reach 200 companies with different forms of support, to develop and test generic and scalable methods and models for companies’ ability to use research and innovation infrastructures in Flemingsberg and Hagastaden, and to increase collaboration between different types of research and innovation infrastructures.
CONTACT FLEMINGSBERG SCIENCE
Johnny Högberg
CEO, Flemingsberg Science
johnny.hogberg@flemingsbergscience.se
+46 70 550 12 73
Pernilla Boström
COO, Flemingsberg Science
pernilla.bostrom@flemingsbergscience.se
+46 703 35 25 77
How can the ATMP facilities at KI and Karolinska support your product development?
Developing Advanced Therapy Medicinal Products (ATMPs) is a growing field. Karolinska Institute and Karolinska University Hospital have unique facilities and expertise in this field.
“We want to increase the interest from the industry to collaborate with researchers”
The pre-GMP laboratory at Karolinska Institutet gives companies the opportunity to develop products, drugs and treatments. It is hoped for an increased interest from the industry to cooperate. Professor Matti Sällberg, head of the pre GMP unit, talks more about how this can be helpful early in the development.
Stockholm Life Tech vital to Flemingsberg’s development
Flemingsberg Science is an active part of Stockholm Life Tech. It develops new opportunities for collaboration and co-operation related to Flemingsberg’s research and innovation infrastructure.
